Orthocell Ltd (ASX: OCC) Share Price and News
Price
Movement
52 Week Range
-
1 Year Return
(20 mins delayed)
() Chart and Price Data
Share Price
Previous Close
Volume
Day Change
Open
Monthly Average Volume
52 Week Range
-
Days Range
-
Turnover
Fundamental Company Figures
Data provided by Morningstar.
Market Cap
$91.56 million
P/E Ratio
N/A
Dividend Yield
N/A
Shares Outstanding
188.79 million
Earnings per share
-0.036
Dividend per share
N/A
Year To Date Return
8.89%
Earnings Yield
N/A
Franking
N/A
Orthocell Ltd (ASX: OCC) Latest News
Why the Orthocell (ASX:OCC) share price is edging higher today
Aaron Teboneras | March 3, 2021 3:16pm
Why is the Orthocell (ASX:OCC) share price falling today?
Aaron Teboneras | February 15, 2021 2:02pm
Why the Orthocell (ASX:OCC) share price is on the rise
Aaron Teboneras | February 5, 2021 2:05pm
Why the Orthocell (ASX:OCC) share price is rocketing 23% higher
Aaron Teboneras | January 14, 2021 12:47pm
Why the Orthocell (ASX:OCC) share price has popped 6% today
Aaron Teboneras | December 23, 2020 12:57pm
Why the Orthocell (ASX:OCC) share price is edging higher today
Aaron Teboneras | December 17, 2020 2:49pm
Orthocell (ASX:OCC) share price jumps 17% on positive clinical trials
Lina Lim | November 20, 2020 11:43am
The Orthocell share price is going nuts on claims of a blockbuster medical breakthrough
Tom Richardson | October 9, 2019 3:59pm
Recent Stock Announcements
Price Sensitive OnlyAn announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Show All
| Date | Heading | An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security. | Time | Pages | File Size |
|---|---|---|---|---|---|
About Orthocell Ltd (ASX: OCC)
Orthocell Ltd is a regenerative medicine company. The company is engaged in the development and commercialisation of cell therapies and related technologies. Its product includes CelGro is a naturally derived collagen medical device for tissue repair and Ortho-ATI is a first-in-class cell therapy for the treatment of chronic tendon injuries.
Share Price History
Data provided by Morningstar.| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 05 Mar 2021 | $0.49 | $-0.01 | -2.04% | 537,043 | $0.50 | $0.50 | $0.48 |
| 04 Mar 2021 | $0.49 | $-0.03 | -5.83% | 466,623 | $0.52 | $0.52 | $0.49 |
| 03 Mar 2021 | $0.52 | $0.01 | 1.96% | 420,210 | $0.53 | $0.54 | $0.51 |
| 02 Mar 2021 | $0.51 | $-0.02 | -3.81% | 275,633 | $0.53 | $0.53 | $0.51 |
| 01 Mar 2021 | $0.53 | $0.00 | 0.00% | 494,213 | $0.52 | $0.53 | $0.50 |
| 26 Feb 2021 | $0.53 | $-0.02 | -3.70% | 783,932 | $0.53 | $0.53 | $0.51 |
| 25 Feb 2021 | $0.54 | $0.00 | 0.00% | 193,692 | $0.54 | $0.54 | $0.53 |
| 24 Feb 2021 | $0.54 | $-0.01 | -1.82% | 130,757 | $0.55 | $0.55 | $0.54 |
| 23 Feb 2021 | $0.55 | $-0.01 | -1.80% | 180,734 | $0.56 | $0.56 | $0.54 |
| 22 Feb 2021 | $0.56 | $0.02 | 3.70% | 195,824 | $0.55 | $0.56 | $0.54 |
| 19 Feb 2021 | $0.54 | $-0.02 | -3.57% | 280,313 | $0.56 | $0.56 | $0.54 |
| 18 Feb 2021 | $0.56 | $-0.01 | -1.74% | 213,450 | $0.58 | $0.58 | $0.55 |
| 17 Feb 2021 | $0.58 | $0.00 | 0.00% | 634,213 | $0.58 | $0.58 | $0.57 |
| 16 Feb 2021 | $0.58 | $0.02 | 3.64% | 746,998 | $0.55 | $0.58 | $0.55 |
| 15 Feb 2021 | $0.55 | $-0.01 | -1.79% | 1,182,435 | $0.56 | $0.58 | $0.54 |
| 12 Feb 2021 | $0.56 | $-0.01 | -1.74% | 342,849 | $0.56 | $0.57 | $0.55 |
| 11 Feb 2021 | $0.58 | $0.01 | 1.77% | 353,825 | $0.57 | $0.58 | $0.56 |
| 10 Feb 2021 | $0.57 | $0.00 | 0.00% | 165,117 | $0.56 | $0.57 | $0.56 |
| 09 Feb 2021 | $0.56 | $-0.02 | -3.45% | 654,583 | $0.58 | $0.59 | $0.56 |
| 08 Feb 2021 | $0.58 | $0.02 | 3.60% | 1,452,736 | $0.56 | $0.58 | $0.56 |
| 05 Feb 2021 | $0.56 | $0.03 | 5.66% | 1,477,820 | $0.55 | $0.56 | $0.52 |
| 04 Feb 2021 | $0.53 | $-0.01 | -1.87% | 214,484 | $0.54 | $0.54 | $0.52 |
Director Transactions
Data provided by Morningstar.
Show more
Directors & Management
Data provided by Morningstar.
Show more
Top Share Holders
Data provided by Morningstar.| Name | Shares | Capital |
|---|---|---|
| Ming Hao Zheng & Fan Ying | 7,564,860 | 4.09% |
| Mr Paul Frederick Anderson & Ms Nicole Jane Telford | 6,403,335 | 3.47% |
| Mr Qixiao Zhou | 5,996,241 | 3.24% |
| Mr Jia Xun Xu | 5,168,276 | 2.80% |
| National Nominees Limited | 3,009,595 | 1.63% |
| Hsbc Custody Nominees (Australia) Limited | 2,552,047 | 1.38% |
| Citicorp Nominees Pty Limited | 1,642,909 | 0.89% |
| Dr John Clifford Philpott | 1,472,059 | 0.80% |
| Dr John Clifford Philpott & Mrs Rebecca Anne Philpott | 1,333,902 | 0.72% |
| CS Fourth Nominees (Australia) Limited | 1,327,194 | 0.72% |
| Bond Street Custodians Limited | 1,100,000 | 0.60% |
| Aris Nominees Pty Ltd | 1,042,816 | 0.56% |
| Mr Scott Anthony Walden | 980,000 | 0.53% |
| Murdoch Ventures Pty Ltd | 923,841 | 0.50% |
| Mr Vance Clark Moore | 820,000 | 0.44% |
| Diamonex Ltd | 768,091 | 0.42% |
| Benoni Pty Ltd | 750,000 | 0.41% |
| Mr Tony Athas & Mrs Angela Athas | 730,000 | 0.40% |
| BNP Paribas Nominees Pty Ltd | 718,808 | 0.39% |
| Gwalla Pty Ltd | 700,000 | 0.38% |